Aclarion, Inc. Files 8-K: Key Corporate Updates
Ticker: ACONW · Form: 8-K · Filed: Jul 7, 2025 · CIK: 1635077
| Field | Detail |
|---|---|
| Company | Aclarion, INC. (ACONW) |
| Form Type | 8-K |
| Filed Date | Jul 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, regulation-fd, financial-reporting
Related Tickers: ACON
TL;DR
Aclarion (ACON) filed an 8-K on July 7th covering votes, Reg FD, and financials. Standard corporate update.
AI Summary
Aclarion, Inc. filed an 8-K on July 7, 2025, reporting on matters submitted to a vote of security holders, Regulation FD disclosures, and financial statements. The company, formerly Nocimed, Inc., is incorporated in Delaware and headquartered in Broomfield, Colorado.
Why It Matters
This filing provides essential updates on corporate governance and financial reporting for Aclarion, Inc., which is important for investors to understand the company's current status and compliance.
Risk Assessment
Risk Level: low — This is a routine 8-K filing detailing corporate events and disclosures, not indicating any immediate financial distress or significant operational change.
Key Numbers
- 001-41358 — SEC File Number (Identifies the company's filing history with the SEC.)
- 47-3324725 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Aclarion, Inc. (company) — Registrant
- Nocimed, Inc. (company) — Former company name
- July 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Broomfield, Colorado (location) — Business address city and state
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.
What is the significance of the Regulation FD Disclosure item?
This item signifies that Aclarion, Inc. is making disclosures that comply with Regulation Fair Disclosure, ensuring that material information is broadly disseminated.
What types of financial statements and exhibits are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these statements and exhibits is not detailed in the provided text.
When did Aclarion, Inc. change its name from Nocimed, Inc.?
The filing states the date of the name change from Nocimed, Inc. to Aclarion, Inc. was February 26, 2015.
What is Aclarion, Inc.'s primary business classification?
Aclarion, Inc. is classified under Standard Industrial Classification code 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding Aclarion, Inc. (ACONW).